Musk’s cuts: At a cabinet meeting on Thursday, Elon Musk indicated his Department of Government Efficiency was on pace to cut ...

40 mins: Another Munster lineout goes to pot, this time at the front as Coombes is beaten in the air. Mercifully for the ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

Welcome to CureVac fourth-quarter and full year 2024 financial results and business update call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices ...

Strategic Milestone Achievement and Increased Financial Discipline Underscore Year of Corporate TransformationCompleted enrollment of Part B of Phase 1 glioblastoma study with investigational precisio ...

In response to the recent positive preclinical weight loss data with NPM-139, Vivani is now planning to advance ... regulatory clearance, initiation of an initial clinical trial. Vivani previously ...

SAB BIO (Nasdaq: SABS), ("SAB BIO" or the "Company"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

Good morning and welcome to PAVmed fourth-quarter 2024 business update conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over ...

Q4 2024 Earnings Call Transcript March 31, 2025 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.61, ...

ASX health stocks broke their losing streak this week, while it was a big week for Nanosonics, Neurizon and Sigma.

Pulse Biosciences, Inc. (NASDAQ: PLSE) Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.